Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier-Kohler, Carmen Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Dechend, Ralf Priv. Doz. (1) Gösele, Claudia Dr. (1) Hinz, Michael Dr. (2) Hübner, Norbert Prof. Dr. (16) Langanki, Reika (1) Lee, Young-Ae Prof. Dr. (2) Luft, Friedrich Prof. Dr. (1) Lusatis, Simone (1) Maatz, Henrike Dr. (1) Marenholz, Ingo Dr. (1) Müller, Dominik Prof. Dr. (1) Pilz, Bernhard Dr. (1) Scheidereit, Claus Prof. Dr. (4) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (6) (-) Mathas, Stephan Dr. (10) (-) Saar, Kathrin Dr. (2) (-) Selbach, Matthias Prof. Dr. (7) (-) Biologie maligner Lymphome (13) (-) Genetik und Genomik von Herz- Kreislauferkrankungen (3) (-) Proteom Dynamik (7) (-) 1999 (4) 2000 (2) 2001 (4) (-) 2002 (9) 2003 (4) 2004 (5) 2005 (7) (-) 2006 (9) 2007 (7) 2008 (13) 2009 (13) 2010 (10) 2011 (13) 2012 (11) 2013 (14) 2014 (19) 2015 (16) 2016 (13) 2017 (12) 2018 (12) 2019 (6) 2020 (15) 2021 (18) 2022 (20) 2023 (15) 2024 (5) 22 Ergebnisse: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Saar, Kathrin Dr.Selbach, Matthias Prof. Dr.Biologie maligner LymphomeGenetik und Genomik von Herz- KreislauferkrankungenProteom Dynamik199920022006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 1999 / Blood Overexpression of IkappaBalpha without inhibition of NF-kappaB activity and mutations in the IkappaBalpha gene in Reed-Sternberg cells F. Emmerich M. Meiser M. Hummel G. Demel H.D. Foss F. Jundt S. Mathas D. Krappmann C. Scheidereit H. Stein B. Dörken 01. Januar 1999 / Onkologe Regulation des Zellzyklus und therapeutische Implikationen H.D. Royer E. Grinstein M. Janz 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. November 1999 / Blood Overexpression of IkappaBalpha without inhibition of NF-kappaB activity and mutations in the IkappaBalpha gene in Reed-Sternberg cells F. Emmerich M. Meiser M. Hummel G. Demel H.D. Foss F. Jundt S. Mathas D. Krappmann C. Scheidereit H. Stein B. Dörken
01. Januar 1999 / Onkologe Regulation des Zellzyklus und therapeutische Implikationen H.D. Royer E. Grinstein M. Janz
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken